Class I recall: OPTIMAL BALANCE PHARMACY: Glutathione 200 mg/mL, 30 mL sterile multidose vial, Each vial contains: Glutath
FDA reports a Class I recall of Optimal Balance Pharmacy's Glutathione 200 mg/mL sterile multidose injection vials, compounded for IM or IV use, after out-of-specification results were obtained for bacterial endotoxin, indicating microbial contamination of the sterile product. Class I recalls denote a reasonable probability that use of the product could cause serious adverse health consequences or death, as classified by FDA.
Most relevant for: Clinicians and patients using compounded injectable glutathione products from this pharmacy for IM or IV administration.
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More oncology updates
- ASCO updates living guideline on advanced biliary tract cancer careOct 14, 2026
- Hypofractionated PMRT Noninferior to Conventional in Reconstruction PatientsOct 12, 2026
- Tomosynthesis screening shows lower interval cancer rate than mammographyOct 9, 2026
- Metastasis-directed ablation fails to improve PFS in oligometastatic breast cancer trialOct 7, 2026
- Updated pediatric guideline on antibacterial and antifungal prophylaxis in cancerOct 2, 2026